Actelion Ltd Rating Increased to Preferred List at UBS AG (ATLN)
Actelion Ltd (VTX:ATLN) was upgraded by equities researchers at UBS AG to a “preferred list” rating in a research report issued on Friday, Analyst Ratings Network.com reports.
Shares of Actelion Ltd (VTX:ATLN) traded up 1.66% on Friday, hitting CHK 64.15. 347,894 shares of the company’s stock traded hands. Actelion Ltd has a 52-week low of CHK 42.85 and a 52-week high of CHK 66.25. The stock has a 50-day moving average of CHK 63.88 and a 200-day moving average of CHK 57.67.
Several other analysts have also recently commented on the stock. Analysts at AlphaValue reiterated an “add” rating on shares of Actelion Ltd (VTX:ATLN) in a research note to investors on Thursday, July 11th. They now have a CHF 63.40 price target on the stock. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Actelion Ltd (VTX:ATLN) in a research note to investors on Monday, July 8th. They now have a CHF 60 price target on the stock.
Actelion Ltd is a Switzerland-based biopharmaceutical holding company that focuses on the discovery, development and commercialization of small molecule drugs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.